More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Combining liraglutide with a very low-calorie ketogenic diet can lead to greater weight loss than the diet alone in adults ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns ...

The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...

Here's how to stay in a deficit safely. If you’re trying to lose weight, it’s natural to want an efficient solution. During ...

Scientists have found that cutting cysteine triggers fat to burn energy instead of storing it. This shift from white to brown ...

Obesity is a worldwide problem that is increasing. It also is associated with ocular problems. A recent study found that in ...

SHREVEPORT, La. - A new drug developed by Eli Lily works in a unique way compared to treatments already on the market, like ...